Català-Mora, J., Mora, J., Simao, M., Munier, F., Romero, L., Fu, L., Ardila, J., Russo, I., Zamarripa, K. S., Díaz-Cascajosa, J., Pedemonte-Sarrias, E., Barraso-Rodrigo, M., Colmenero, I. A., Molies-Navarrete, D., Mato-Berciano, A., Blasco, C., Cascallo, M., Chantada, G. L., Montero-Carcaboso, Ã. (2025). A phase I dose-escalation study to assess the oncolytic virus VCN-01 safety and efficacy in refractory retinoblastoma patients.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.10046